Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, January 25, 2015
 
Register | Sign in
Home Page>Products
  Product News
Chemistry on Wheels
Friday, December 26, 2014
Evonik’s EcoTrainer is flexible, clever and smart: a single container can house a complete chemical production complex.

High Quality Affordable Reaction Vessels
Friday, December 26, 2014
Addition of the AG! reactor vessel range extends the scale of reactors up to 160 L, or up to 60 L.

Bruker Introduces BioScope Resolve High-Resolution BioAFM System
Friday, December 26, 2014
Featuring PeakForce Tapping for quantitative bio-mechanical property mapping.

Tissue Culture Plastics & Epigenetic Supplies
Tuesday, December 23, 2014
New 2015 catalogue from Porvair Sciences.

Activ8rlives to Develop its First Medical Smartwatch
Friday, December 19, 2014
BuddyWOTCH for continuous monitoring of oxygenation for UK’s Chronic Obstructive Pulmonary Disease patients.

Ebola Antigens and Antibodies for ELISA
Friday, December 19, 2014
AMSBIO products for the development of an ELISA detection assay for the Ebola virus.

Exiqon Launches Two New Research Use Only Kits
Friday, December 19, 2014
The miRSIGN™ miR-21 Oncogene assay and the miRSIGN™ Colon Cancer assay for PCR analysis of colon cancer samples.

Bruker Releases ONET Software
Thursday, December 18, 2014
New networking software for administration of FT-NIR spectrometer networks.

New Tool for High Strain Rate Materials Testing
Thursday, December 18, 2014
Specialized Imaging Kirana camera create high-resolution images of the ultra high-speed events.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 10830
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn